The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

We are excited to reach this important milestone in the Expander-2 Pivotal Trial,” said Paul Edwards, President and CEO of Prodeon Medical. “Completing enrollment is a key step in our mission to ...

CHI Memorial Hospital has added a urinary tract infection clinic to its host of services. The clinic provides comprehensive ...

Medically reviewed by Qin Rao, MD Abdominal pain while peeing is a symptom of numerous health conditions. It could be from a ...

Medically reviewed by Jennifer Steinhoff, MD The groin is located where the upper part of the thighs meets the lowest parts ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...

Editors and writers independently select products unless marked Sponsored or Promoted. Sponsored content is a paid ad, while content marked Promoted is chosen by Ziff Davis leadership. We may earn ...

B.D. ANSWER: You had obstruction of the urinary tract. In adult men, the most common cause by far is prostate ... The urologist will discuss your options, including medications and procedures to ...

B.D. Answer: You had obstruction of the urinary tract. In adult men, the most common cause by ... The urologist will discuss your options, including medications and procedures to shrink the ...

As a result, men over 50 may benefit from a multivitamin ... their intake of vitamin K because it could interact with their medication. In addition to being certified gluten-free, New Chapter ...